Rapid screening of MCM efficacy against sars-COV-2 pseudoviruses with spike variants
Ended Purchase Order Awarded Last action
- Contract number
- 75A50121P00054
- Awardee
-
Monogram Biosciences, Inc. UEI LFM3XDVK31M7
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $3,351,920
Award facts
- Opportunity
-
- Rapid Screening of MCM Efficacy Against SARS-CoV-2 Pseudoviruses with Spike Variants Solicitation · 75A50121R00033 · Posted Apr 6, 2021
- Contract value 37% obligated
-
- $3,351,920.00 Current, with exercised options
- $9,109,520.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$1,409,960 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $796,880 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $3,965,000 |
About this award
This firm fixed-price contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Monogram Biosciences, Inc., a for-profit subsidiary of Laboratory Corporation of America Holdings. The $9,109,520.00 contract requires Monogram Biosciences to provide rapid screening and testing services to evaluate the efficacy of medical countermeasures against SARS-CoV-2 pseudoviruses, including emerging variants. The base period involves validating a pseudovirus neutralization assay, producing and testing up to 250 pseudoviruses, and testing up to 100 medical countermeasures. The contract has 26 option periods to test additional pseudoviruses and prepare manuscripts. This contract award was not set aside for any socioeconomic categories. Monogram Biosciences has received over $70 million in prior HHS contracts related to COVID-19 testing and research.
Quick answers
Who was awarded contract 75A50121P00054?
75A50121P00054 was awarded to Monogram Biosciences, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 20, 2021.
How much is contract 75A50121P00054 worth?
The government has obligated $3,351,920 on 75A50121P00054. Its potential value, with all options, is $9,109,520.
Was contract 75A50121P00054 competed?
The extent of competition for 75A50121P00054 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award